»  Immediate results of the exam will be available, relieving patient anxiety.

»  A detailed diagnostic map of the cervix will be generated. Unlike the Pap test, the bioprobe will record all sampling by location so that a suspect

    reading in a particular place can be monitored on a regular basis.

»  A sophisticated visual graphic display will provide clear presentation of results.

»  The increased density of data and the independence of the data components will allow the diagnosis to be extremely accurate, which should
    reduce the frequency of ambiguous reports commonly reported by the Pap test.

»  The Preciva test will be more comfortable and will not abrade the cervix.

»  The device will provide feedback to the operator so that the endocervical canal is tested and the complete cervix is examined.

»  The handpiece will rotate automatically and position accurately without the need for highly proficient operators.

»  The system will allow the practitioner to use an expert system inexpensively at the place of the primary physician rather than by referral.

»  The diagnosis will not be subjective or depend on laboratory infrastructure.

»  The continuity of structures across a surface and down through tissue layers will be used to refine tissue diagnosis.

»  The device can be modified for use as a guide for tissue biopsy.